Uranium Royalty (NASDAQ:UROY) Stock Keeps Buy Rating at HC Wainwright

Posted by Brenda Bartman on Oct 19th, 2026

Uranium Royalty (NASDAQ:UROY – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report released on Monday, Benzinga reports. They currently have a $4.50 target price on the stock. HC Wainwright’s target price indicates a potential upside of 28.02% from the stock’s previous close.

UROY has been the subject of several other research reports. Weiss Ratings upgraded shares of Uranium Royalty from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Zacks Research downgraded shares of Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Finally, National Bank Financial began coverage on shares of Uranium Royalty in a research note on Wednesday, July 29th. They set an “outperform” rating and a $3.75 price target on the stock. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Uranium Royalty presently has an average rating of “Moderate Buy” and a consensus target price of $4.25.

Read Our Latest Analysis on Uranium Royalty

Uranium Royalty Stock Down 0.7%

Shares of UROY stock traded down $0.03 on Monday, reaching $3.52. 1,227,560 shares of the stock were exchanged, compared to its average volume of 2,962,896. Uranium Royalty has a twelve month low of $2.56 and a twelve month high of $5.52. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of 39.06 and a beta of 1.57. The company has a current ratio of 0.88, a quick ratio of 0.87 and a debt-to-equity ratio of 0.49. The business’s 50 day moving average price is $4.21 and its 200 day moving average price is $3.65.

Uranium Royalty (NASDAQ:UROY – Get Free Report) last issued its earnings results on Monday, September 14th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.05. The business had revenue of $51.68 million for the quarter, compared to analyst estimates of $52.23 million. Uranium Royalty had a return on equity of 10.86% and a net margin of 25.88%. As a group, sell-side analysts expect that Uranium Royalty will post 0.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Uranium Royalty

Institutional investors and hedge funds have recently made changes to their positions in the business. Squarepoint Ops LLC acquired a new stake in shares of Uranium Royalty in the 2nd quarter worth $397,000. AXQ Capital LP purchased a new position in shares of Uranium Royalty during the 2nd quarter worth $37,000. Bank of America Corp DE acquired a new position in shares of Uranium Royalty in the 2nd quarter valued at $129,000. Hsbc Holdings PLC purchased a new stake in Uranium Royalty during the second quarter worth approximately $174,000. Finally, The Manufacturers Life Insurance Company purchased a new position in Uranium Royalty in the 2nd quarter worth approximately $402,000. 24.19% of the stock is owned by hedge funds and other institutional investors.

About Uranium Royalty

(Get Free Report)

Uranium Royalty Corp. (NASDAQ: UROY) is a uranium-focused royalty and streaming company. It seeks exposure to the uranium sector through a portfolio of royalties, streams, debt and equity investments in uranium projects, as well as holdings of physical uranium. The company does not primarily operate mines; instead, its business model is designed to provide participation in uranium production and prices without directly bearing the full costs of mine development and operation.

Its interests are tied to uranium projects and properties in established producing and prospective regions, including Canada, the United States and Australia.